Premature arteriosclerosis and thromboembolic events are well-known complications of homozygous homocystinuria due to cystathionine synthase deficiency. It is unknown whether heterozygosity for homocystinuria predisposes to premature vascular disease. We explored the frequency of excessive homocysteine accumulation after standardized methionine loading in 75 patients presenting with clinical signs of ischemic disease before the age of 50:25 with occlusive peripheral arterial disease, 25 with occlusive cerebrovascular disease, and 25 with myocardial infarction. In seven patients in each of the first two groups but in none of the patients in the third group, heterozygosity for homocystinuria was established on the basis of pathological homocysteinemia after methionine loading and cystathionine synthase deficiency in skin fibroblast cultures. Because the frequency of heterozygosity for homocystinuria in the normal population is 1 in 70 at the most, we conclude that this condition predisposes to the development of premature occlusive arterial disease, causing intermittent claudication, renovascular hypertension, and ischemic cerebrovascular disease.
This article has been cited by other articles:
Mohan, I. V., Jagroop, I. A., Mikhailidis, D. P., Stansby, G. P.
(2008). Homocysteine Activates Platelets In Vitro. CLIN APPL THROMB HEMOST
14: 8-18
[Abstract]
Meng, Q. H., Yang, G., Yang, W., Jiang, B., Wu, L., Wang, R.
(2007). Protective Effect of Hydrogen Sulfide on Balloon Injury-Induced Neointima Hyperplasia in Rat Carotid Arteries. Am. J. Pathol.
170: 1406-1414
[Abstract][Full Text]
Refsum, H., Nurk, E., Smith, A. D., Ueland, P. M., Gjesdal, C. G., Bjelland, I., Tverdal, A., Tell, G. S., Nygard, O., Vollset, S. E.
(2006). The Hordaland Homocysteine Study: A Community-Based Study of Homocysteine, Its Determinants, and Associations with Disease. J. Nutr.
136: 1731S-1740S
[Abstract][Full Text]
Carlson, C. S., Heagerty, P. J., Hatsukami, T. S., Richter, R. J., Ranchalis, J., Lewis, J., Bacus, T. J., McKinstry, L. A., Schellenberg, G. D., Rieder, M., Nickerson, D., Furlong, C. E., Chait, A., Jarvik, G. P.
(2006). TagSNP analyses of the PON gene cluster: effects on PON1 activity, LDL oxidative susceptibility, and vascular disease. J. Lipid Res.
47: 1014-1024
[Abstract][Full Text]
De Luca, G., Suryapranata, H., Gregorio, G., Lange, H., Chiariello, M.
(2005). Homocysteine and Its Effects on In-Stent Restenosis. Circulation
112: e307-e311
[Full Text]
Ernest, S., Hosack, A., O'Brien, W. E., Rosenblatt, D. S., Nadeau, J. H.
(2005). Homocysteine levels in A/J and C57BL/6J mice: genetic, diet, gender, and parental effects. Physiol. Genomics
21: 404-410
[Abstract][Full Text]
Toole, J. F., Malinow, M. R., Chambless, L. E., Spence, J. D., Pettigrew, L. C., Howard, V. J., Sides, E. G., Wang, C.-H., Stampfer, M.
(2004). Lowering Homocysteine in Patients With Ischemic Stroke to Prevent Recurrent Stroke, Myocardial Infarction, and Death: The Vitamin Intervention for Stroke Prevention (VISP) Randomized Controlled Trial. JAMA
291: 565-575
[Abstract][Full Text]
WANG, R.
(2002). Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?. FASEB J.
16: 1792-1798
[Abstract][Full Text]
Ratnam, S., Maclean, K. N., Jacobs, R. L., Brosnan, M. E., Kraus, J. P., Brosnan, J. T.
(2002). Hormonal Regulation of Cystathionine beta -Synthase Expression in Liver. J. Biol. Chem.
277: 42912-42918
[Abstract][Full Text]
Homocysteine Studies Collaboration,
(2002). Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis. JAMA
288: 2015-2022
[Abstract][Full Text]
Robinson, K.
(2002). Homocysteine and vascular disease. Eur Heart J
23: 1482-1484
[Full Text]
Kittner, S. J.
(2002). Stroke in the young: Coming of age. Neurology
59: 6-7
[Full Text]
Sen, S., Oppenheimer, S. M., Lima, J., Cohen, B.
(2002). Risk Factors for Progression of Aortic Atheroma in Stroke and Transient Ischemic Attack Patients. Stroke
33: 930-935
[Abstract][Full Text]
van der Griend, R., Biesma, D. H, Banga, J.-D.
(2002). Postmethionine-load homocysteine determination for the diagnosis hyperhomocysteinaemia and efficacy of homocysteine lowering treatment regimens. Vasc Med
7: 29-33
[Abstract]
Ford, E. S, Smith, S J., Stroup, D. F, Steinberg, K. K, Mueller, P. W, Thacker, S. B
(2002). Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int J Epidemiol
31: 59-70
[Abstract][Full Text]
Yap, S., Boers, G. H.J., Wilcken, B., Wilcken, D. E.L., Brenton, D. P., Lee, P. J., Walter, J. H., Howard, P. M., Naughten, E. R.
(2001). Vascular Outcome in Patients With Homocystinuria due to Cystathionine {beta}-Synthase Deficiency Treated Chronically: A Multicenter Observational Study. Arterioscler. Thromb. Vasc. Bio.
21: 2080-2085
[Abstract][Full Text]
Hessner, M. J., Dinauer, D. M., Kwiatkowski, R., Neri, B., Raife, T. J.
(2001). Age-dependent Prevalence of Vascular Disease-associated Polymorphisms among 2689 Volunteer Blood Donors. Clin. Chem.
47: 1879-1884
[Abstract][Full Text]
Knekt, P., Reunanen, A., Alfthan, G., Heliovaara, M., Rissanen, H., Marniemi, J., Aromaa, A.
(2001). Hyperhomocystinemia: A Risk Factor or a Consequence of Coronary Heart Disease?. Arch Intern Med
161: 1589-1594
[Abstract][Full Text]
Bick, R.
(2001). State-of-the-Art Review: Vascular Thrombohemorrhagic Disorders: Hereditary and Acquired. CLIN APPL THROMB HEMOST
7: 178-194
Hanson, N. Q., Aras, O., Yang, F., Tsai, M. Y.
(2001). C677T and A1298C Polymorphisms of the Methylenetetrahydrofolate Reductase Gene: Incidence and Effect of Combined Genotypes on Plasma Fasting and Post-Methionine Load Homocysteine in Vascular Disease. Clin. Chem.
47: 661-666
[Abstract][Full Text]
Saw, S.-M., Yuan, J.-M., Ong, C.-N., Arakawa, K., Lee, H.-P., Coetzee, G. A, Yu, M. C
(2001). Genetic, dietary, and other lifestyle determinants of plasma homocysteine concentrations in middle-aged and older Chinese men and women in Singapore. Am. J. Clin. Nutr.
73: 232-239
[Abstract][Full Text]
Tegos, T. J., Kalodiki, E., Sabetai, M. M., Nicolaides, A. N.
(2001). The Genesis of Atherosclerosis and Risk Factors: A Review. ANGIOLOGY
52: 89-98
[Abstract]
Tribouilloy, C. M., Peltier, M., Iannetta Peltier, M. C., Trojette, F., Andrejak, M., Lesbre, J.-P. M.
(2000). Plasma Homocysteine and Severity of Thoracic Aortic Atherosclerosis. Chest
118: 1685-1689
[Abstract][Full Text]
Hassan, A., Markus, H. S.
(2000). Genetics and ischaemic stroke. Brain
123: 1784-1812
[Abstract][Full Text]
Brattstrom, L., Wilcken, D. E.
(2000). Homocysteine and cardiovascular disease: cause or effect?. Am. J. Clin. Nutr.
72: 315-323
[Abstract][Full Text]
Willcutts, K., Minasi, J. S.
(2000). Use of B Vitamins to Reduce Homocysteine in Chronic Mesenteric Ischemia. Nutr Clin Pract
15: 171-173
[Abstract]
Essama-Tjani, J.-C., Guilland, J.-C., Potier de Courcy, G., Fuchs, F., Richard, D.
(2000). Folate Status Worsens in Recently Institutionalized Elderly People without Evidence of Functional Deterioration. J. Am. Coll. Nutr.
19: 392-404
[Abstract][Full Text]
Valentine, R. J., Verstraete, R., Clagett, G. P., Cohen, J. C.
(2000). Premature Cardiovascular Disease Is Common in Relatives of Patients With Premature Peripheral Atherosclerosis. Arch Intern Med
160: 1343-1348
[Abstract][Full Text]
Pavlakis, S. G., Kingsley, P. B., Bialer, M. G.
(2000). Stroke in Children: Genetic and Metabolic Issues. J Child Neurol
15: 308-315
[Abstract]
Ungvari, Z., Sarkadi-Nagy, E., Bagi, Z., Szollar, L., Koller, A.
(2000). Simultaneously Increased TxA2 Activity in Isolated Arterioles and Platelets of Rats With Hyperhomocysteinemia. Arterioscler. Thromb. Vasc. Bio.
20: 1203-1208
[Abstract][Full Text]
Christen, W. G., Ajani, U. A., Glynn, R. J., Hennekens, C. H.
(2000). Blood Levels of Homocysteine and Increased Risks of Cardiovascular Disease: Causal or Casual?. Arch Intern Med
160: 422-434
[Abstract][Full Text]
ROBINSON, K.
(2000). Homocysteine, B vitamins, and risk of cardiovascular disease. Heart
83: 127-130
[Full Text]
Stoiser, B., Thalhammer, F., El-Menyawi, I., Wilfing, A., Daxbock, F., Locker, G. J., Burgmann, H.
(2000). Homocysteine and Laminin Are Not Prognostic Markers in Patients with Septic Inflammatory Response Syndrome. CVI
7: 119-121
[Abstract][Full Text]
Chambers, J. C., Obeid, O. A., Kooner, J. S.
(1999). Physiological Increments in Plasma Homocysteine Induce Vascular Endothelial Dysfunction in Normal Human Subjects. Arterioscler. Thromb. Vasc. Bio.
19: 2922-2927
[Abstract][Full Text]
Rubattu, S., Ridker, P., Stampfer, M. J., Volpe, M., Hennekens, C. H., Lindpaintner, K.
(1999). The Gene Encoding Atrial Natriuretic Peptide and the Risk of Human Stroke. Circulation
100: 1722-1726
[Abstract][Full Text]
Fonseca, V., Guba, S. C., Fink, L. M.
(1999). Hyperhomocysteinemia and the Endocrine System: Implications for Atherosclerosis and Thrombosis. Endocr. Rev.
20: 738-759
[Abstract][Full Text]
Harjai, K. J.
(1999). Potential New Cardiovascular Risk Factors: Left Ventricular Hypertrophy, Homocysteine, Lipoprotein(a), Triglycerides, Oxidative Stress, and Fibrinogen. ANN INTERN MED
131: 376-386
[Abstract][Full Text]
Ungvari, Z., Pacher, P., Rischak, K., Szollar, L., Koller, A.
(1999). Dysfunction of Nitric Oxide Mediation in Isolated Rat Arterioles With Methionine Diet–Induced Hyperhomocysteinemia. Arterioscler. Thromb. Vasc. Bio.
19: 1899-1904
[Abstract][Full Text]
Lambert, J., van den Berg, M., Steyn, M., Rauwerda, J. A., Donker, A. J.M., Stehouwer, C. D.A.
(1999). Familial hyperhomocysteinaemia and endothelium-dependent vasodilatation and arterial distensibility of large arteries. Cardiovasc Res
42: 743-751
[Abstract][Full Text]
Spence, J. D., Malinow, M. R., Barnett, P. A., Marian, A. J., Freeman, D., Hegele, R. A.
(1999). Plasma Homocyst(e)ine Concentration, But Not MTHFR Genotype, Is Associated With Variation in Carotid Plaque Area. Stroke
30: 969-973
[Abstract][Full Text]
Kristensen, B., Malm, J., Nilsson, T. K., Hultdin, J., Carlberg, B., Dahlen, G., Olsson, T.
(1999). Hyperhomocysteinemia and Hypofibrinolysis in Young Adults With Ischemic Stroke. Stroke
30: 974-980
[Abstract][Full Text]
Stolzenberg-Solomon, R. Z, Miller, E. R III, Maguire, M. G, Selhub, J., Appel, L. J
(1999). Association of dietary protein intake and coffee consumption with serum homocysteine concentrations in an older population. Am. J. Clin. Nutr.
69: 467-475
[Abstract][Full Text]
Harmon, D. L., Doyle, R. M., Meleady, R., Doyle, M., Shields, D. C., Barry, R., Coakley, D., Graham, I. M., Whitehead, A. S.
(1999). Genetic Analysis of the Thermolabile Variant of 5,10-Methylenetetrahydrofolate Reductase as a Risk Factor for Ischemic Stroke. Arterioscler. Thromb. Vasc. Bio.
19: 208-211
[Abstract][Full Text]
Morita, H., Kurihara, H., Sugiyama, T., Hamada, C., Kurihara, Y., Shindo, T., Oh-hashi, Y., Yazaki, Y.
(1999). Polymorphism of the Methionine Synthase Gene : Association With Homocysteine Metabolism and Late-Onset Vascular Diseases in the Japanese Population. Arterioscler. Thromb. Vasc. Bio.
19: 298-302
[Abstract][Full Text]
Brattstrom, L., Wilcken, D. E. L., Ohrvik, J., Brudin, L.
(1998). Common Methylenetetrahydrofolate Reductase Gene Mutation Leads to Hyperhomocysteinemia but Not to Vascular Disease : The Result of a Meta-Analysis. Circulation
98: 2520-2526
[Abstract][Full Text]
Morita, H., Kurihara, H., Tsubaki, S.-i., Sugiyama, T., Hamada, C., Kurihara, Y., Shindo, T., Oh-hashi, Y., Kitamura, K., Yazaki, Y.
(1998). Methylenetetrahydrofolate Reductase Gene Polymorphism and Ischemic Stroke in Japanese. Arterioscler. Thromb. Vasc. Bio.
18: 1465-1469
[Abstract][Full Text]
Cleophas, T. J., van der Meulen, J., Morrison, H. I., Ellison, L. F., Schaubel, D., Wigle, D. T., Lowin, L., Herbert, V., Littell, J. T., Rimm, E. B., Willett, W. C., Hu, F. B., Colditz, G. A., Sampson, L., Manson, J. E., Hennekens, C. H., Stampfer, M. J., McCully, K. S.
(1998). Relationship of Dietary Folate and Vitamin B6 With Coronary Heart Disease in Women. JAMA
280: 417-419
[Full Text]
Jacobsen, D. W.
(1998). Homocysteine and vitamins in cardiovascular disease. Clin. Chem.
44: 1833-1843
[Abstract][Full Text]
Chapman, J., Wang, N., Treves, T. A., Korczyn, A. D., Bornstein, N. M.
(1998). ACE, MTHFR, Factor V Leiden, and APOE Polymorphisms in Patients With Vascular and Alzheimer's Dementia. Stroke
29: 1401-1404
[Abstract][Full Text]
Zhang, F., Slungaard, A., Vercellotti, G. M., Iadecola, C.
(1998). Superoxide-dependent cerebrovascular effects of homocysteine. Am. J. Physiol. Regul. Integr. Comp. Physiol.
274: R1704-R1711
[Abstract][Full Text]
Welch, G. N., Loscalzo, J.
(1998). Homocysteine and Atherothrombosis. NEJM
338: 1042-1050
[Full Text]
Robinson, K., Arheart, K., Refsum, H., Brattstrom, L., Boers, G., Ueland, P., Rubba, P., Palma-Reis, R., Meleady, R., Daly, L., Witteman, J., Graham, I.
(1998). Low Circulating Folate and Vitamin B6 Concentrations : Risk Factors for Stroke, Peripheral Vascular Disease, and Coronary Artery Disease. Circulation
97: 437-443
[Abstract][Full Text]
Rimm, E. B., Willett, W. C., Hu, F. B., Sampson, L., Colditz, G. A., Manson, J. E., Hennekens, C., Stampfer, M. J.
(1998). Folate and Vitamin B6 From Diet and Supplements in Relation to Risk of Coronary Heart Disease Among Women. JAMA
279: 359-364
[Abstract][Full Text]
Moghadasian, M. H., McManus, B. M., Frohlich, J. J.
(1997). Homocyst(e)ine and Coronary Artery Disease: Clinical Evidence and Genetic and Metabolic Background. Arch Intern Med
157: 2299-2308
[Abstract]
Kluijtmans, L. A. J., Kastelein, J. J. P., Lindemans, J., Boers, G. H. J., Heil, S. G., Bruschke, A. V. G., Jukema, J. W., van den Heuvel, L. P. W. J., Trijbels, F. J. M., Boerma, G. J. M., Verheugt, F. W. A., Willems, F., Blom, H. J.
(1997). Thermolabile Methylenetetrahydrofolate Reductase in Coronary Artery Disease. Circulation
96: 2573-2577
[Abstract][Full Text]
Kottke-Marchant, K., Green, R., Jacobsen, D. W., Gupta, A., Savon, S. R., Secic, M., Robinson, K.
(1997). High Plasma Homocysteine: A Risk Factor for Arterial and Venous Thrombosis in Patients with Normal Coagulation Profiles. CLIN APPL THROMB HEMOST
3: 239-244
[Abstract]
Evers, S., Koch, H.-G., Grotemeyer, K.-H., Lange, B., Deufel, T., Ringelstein, E.-B.
(1997). Features, Symptoms, and Neurophysiological Findings in Stroke Associated With Hyperhomocysteinemia. Arch Neurol
54: 1276-1282
[Abstract]
Upchurch Jr., G. R., Welch, G. N., Fabian, A. J., Freedman, J. E., Johnson, J. L., Keaney Jr., J. F., Loscalzo, J.
(1997). Homocyst(e)ine Decreases Bioavailable Nitric Oxide by a Mechanism Involving Glutathione Peroxidase. J. Biol. Chem.
272: 17012-17017
[Abstract][Full Text]
D'Angelo, A., Selhub, J.
(1997). Homocysteine and Thrombotic Disease. Blood
90: 1-11
[Full Text]
Verhoef, P., Kok, F. J., Kruyssen, D. A.C.M., Schouten, E. G., Witteman, J. C.M., Grobbee, D. E., Ueland, P. M., Refsum, H.
(1997). Plasma Total Homocysteine, B Vitamins, and Risk of Coronary Atherosclerosis. Arterioscler. Thromb. Vasc. Bio.
17: 989-995
[Abstract][Full Text]
Morita, H., Taguchi, J.-i., Kurihara, H., Kitaoka, M., Kaneda, H., Kurihara, Y., Maemura, K., Minamino, T., Ohno, M., Yamaoki, K., Ogasawara, K., Aizawa, T., Suzuki, S., Yazaki, Y.
(1997). Genetic Polymorphism of 5,10-Methylenetetrahydrofolate Reductase (MTHFR) as a Risk Factor for Coronary Artery Disease. Circulation
95: 2032-2036
[Abstract][Full Text]
Ridker, P. M., Hennekens, C. H., Selhub, J., Miletich, J. P., Malinow, M. R., Stampfer, M. J.
(1997). Interrelation of Hyperhomocyst(e)inemia, Factor V Leiden, and Risk of Future Venous Thromboembolism. Circulation
95: 1777-1782
[Abstract][Full Text]
Christensen, B., Frosst, P., Lussier-Cacan, S., Selhub, J., Goyette, P., Rosenblatt, D. S., Genest, J. Jr, Rozen, R.
(1997). Correlation of a Common Mutation in the Methylenetetrahydrofolate Reductase Gene With Plasma Homocysteine in Patients With Premature Coronary Artery Disease. Arterioscler. Thromb. Vasc. Bio.
17: 569-573
[Abstract][Full Text]
Robinson, K., Gupta, A., Dennis, V., Arheart, K., Chaudhary, D., Green, R., Vigo, P., Mayer, E. L., Selhub, J., Kutner, M., Jacobsen, D. W.
(1996). Hyperhomocysteinemia Confers an Independent Increased Risk of Atherosclerosis in End-Stage Renal Disease and Is Closely Linked to Plasma Folate and Pyridoxine Concentrations. Circulation
94: 2743-2748
[Abstract][Full Text]
Gallagher, P. M., Meleady, R., Shields, D. C., Tan, K. S., McMaster, D., Rozen, R., Evans, A., Graham, I. M., Whitehead, A. S.
(1996). Homocysteine and Risk of Premature Coronary Heart Disease: Evidence for a Common Gene Mutation. Circulation
94: 2154-2158
[Abstract][Full Text]
Wilcken, D. E.L., Wang, X. L., Sim, A. S., McCredie, R. M.
(1996). Distribution in Healthy and Coronary Populations of the Methylenetetrahydrofolate Reductase (MTHFR) C677T Mutation. Arterioscler. Thromb. Vasc. Bio.
16: 878-882
[Abstract][Full Text]
Loehrer, F. M.T., Angst, C. P., Haefeli, W. E., Jordan, P. P., Ritz, R., Fowler, B.
(1996). Low Whole-Blood S-Adenosylmethionine and Correlation Between 5-Methyltetrahydrofolate and Homocysteine in Coronary Artery Disease. Arterioscler. Thromb. Vasc. Bio.
16: 727-733
[Abstract][Full Text]
Kroon, A. A., Aengevaeren, W. R.M., van der Werf, T., Uijen, G. J.H., Reiber, J. H.C., Bruschke, A. V.G., Stalenhoef, A. F.H.
(1996). LDL-Apheresis Atherosclerosis Regression Study (LAARS) : Effect of Aggressive Versus Conventional Lipid Lowering Treatment on Coronary Atherosclerosis. Circulation
93: 1826-1835
[Abstract][Full Text]
den Heijer, M., Koster, T., Blom, H. J., Bos, G. M.J., Briet, E., Reitsma, P. H., Vandenbroucke, J. P., Rosendaal, F. R.
(1996). Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis. NEJM
334: 759-762
[Abstract][Full Text]
Kerrin, D., Murdoch Eaton, D., Livingston, J., Henderson, M., Smith, M.
(1996). Homocystinuria Presenting With Sagittal Sinus Thrombosis in Infancy. J Child Neurol
11: 70-71
van den Berg, M., Stehouwer, C. D.A., Bierdrager, E., Rauwerda, J. A.
(1996). Plasma Homocysteine and Severity of Atherosclerosis in Young Patients With Lower-Limb Atherosclerotic Disease. Arterioscler. Thromb. Vasc. Bio.
16: 165-171
[Abstract][Full Text]
Robinson, K., Mayer, E. L., Miller, D. P., Green, R., van Lente, F., Gupta, A., Kottke-Marchant, K., Savon, S. R., Selhub, J., Nissen, S. E., Kutner, M., Topol, E. J., Jacobsen, D. W.
(1995). Hyperhomocysteinemia and Low Pyridoxal Phosphate : Common and Independent Reversible Risk Factors for Coronary Artery Disease. Circulation
92: 2825-2830
[Abstract][Full Text]
Boushey, C. J., Beresford, S. A. A., Omenn, G. S., Motulsky, A. G.
(1995). A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease: Probable Benefits of Increasing Folic Acid Intakes. JAMA
274: 1049-1057
[Abstract]
Hopkins, P. N., Wu, L. L., Wu, J., Hunt, S. C., James, B. C., Vincent, G. M., Williams, R. R.
(1995). Higher Plasma Homocyst(e)ine and Increased Susceptibility to Adverse Effects of Low Folate in Early Familial Coronary Artery Disease. Arterioscler. Thromb. Vasc. Bio.
15: 1314-1320
[Abstract][Full Text]
Giles, W. H., Kittner, S. J., Anda, R. F., Croft, J. B., Casper, M. L.
(1995). Serum Folate and Risk for Ischemic Stroke : First National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Stroke
26: 1166-1170
[Abstract][Full Text]
Lindgren, A., Brattstrom, L., Norrving, B., Hultberg, B., Andersson, A., Johansson, B. B.
(1995). Plasma Homocysteine in the Acute and Convalescent Phases After Stroke. Stroke
26: 795-800
[Abstract][Full Text]
Mansoor, M. A., Bergmark, C., Svardal, A. M., Lonning, P. E., Ueland, P. M.
(1995). Redox Status and Protein Binding of Plasma Homocysteine and Other Aminothiols in Patients With Early-Onset Peripheral Vascular Disease : Homocysteine and Peripheral Vascular Disease. Arterioscler. Thromb. Vasc. Bio.
15: 232-240
[Abstract][Full Text]
Riela, A. R., Roach, E. S.
(1993). Topical Review Article: Etiology of Stroke in Children. J Child Neurol
8: 201-220
[Abstract]
Cooke, J. P, Creager, M. A
(1991). Management of the patient with intermittent claudication. Vasc Med
2: 19-31
Bell, I. R., Edman, J. S., Miller, J., Hebben, N., Linn, R. T., Ray, D., Kayne, H. L.
(1990). Relationship of Normal Serum Vitamin B12 and Folate Levels to Cognitive Test Performance in Subtypes of Geriatric Major Depression. J Geriatr Psychiatry Neurol
3: 98-105
[Abstract]
